---  
layout: startup_page  
title: "Accure Therapeutics"  
id: "accure.health"  
permalink: "/accuretherapeuticsaccure.health04072025/"  
website: "https://accure.health/"  
funding_round: "Grant"  
funding_amount: "€1.46M"  
investors: "The Michael J. Fox Foundation, Luxembourg National Research Fund (FNR)"  
about: "Accure Therapeutics is a Barcelona-based neuroscience R&D company developing ACT-02, a novel drug candidate with disease-modifying potential for Parkinson's disease. ACT-02 inhibits Prolyl Endopeptidase (PREP), a promising target in Parkinson's. The company is currently in an advanced preclinical stage."  
markets: "Biotechnology, Neuroscience, Pharmaceuticals, HealthTech, Life Sciences"  
hq: "Barcelona, Catalonia, Spain"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/accure-therapeutics"  
twitter: "https://twitter.com/AccureTherapeut"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/accure-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/435462-49"  

date_display: "07-Apr-2025"  
date: "2025-04-07"

# SEO Optimization  
meta_title: "Accure Therapeutics - Grant Funding (€1.46M)"  
meta_description: "Accure Therapeutics, Accure Therapeutics is a Barcelona-based neuroscience R&D company developing ACT-02, a novel drug candidate with disease-modifying potential for Parki..."  
meta_keywords: "Accure Therapeutics, Biotechnology, Neuroscience, Pharmaceuticals, HealthTech, Life Sciences, Grant funding"  
canonical_url: "https://startup.projectstartups.com/accuretherapeuticsaccure.health04072025/"  
---